Boditech Med Inc. (KOSDAQ:206640)
10,690
+20 (0.19%)
Apr 3, 2026, 3:30 PM KST
Boditech Med Market Cap
Boditech Med has a market cap or net worth of 232.43 billion as of April 2, 2026. Its market cap has decreased by -29.17% in one year.
Market Cap
232.43B
Enterprise Value
225.35B
Revenue
162.09B
Ranking
n/a
PE Ratio
9.78
Stock Price
10,690.00
Market Cap Chart
Since September 1, 2015, Boditech Med's market cap has increased from 28.15B to 232.43B, an increase of 725.62%. That is a compound annual growth rate of 22.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 232.86B | -18.52% |
| Dec 30, 2025 | 285.80B | -22.50% |
| Dec 30, 2024 | 368.76B | -18.12% |
| Dec 28, 2023 | 450.36B | 100.01% |
| Dec 29, 2022 | 225.17B | -41.09% |
| Dec 30, 2021 | 382.21B | -29.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CMG Pharmaceutical | 263.16B |
| BNC Korea | 256.82B |
| Hyundai Pharmaceutical | 254.63B |
| HLB Pharmaceutical | 225.10B |
| Chong Kun Dang Holdings | 222.56B |
| Samjin Pharmaceuticals | 220.03B |
| Daewon Pharmaceutical | 218.19B |
| Samil Pharmaceutical Co.,Ltd | 210.60B |